Published in Infect Immun on August 01, 2002
Suppression of the inflammatory immune response prevents the development of chronic biofilm infection due to methicillin-resistant Staphylococcus aureus. Infect Immun (2011) 1.13
Role of interleukin-17A in cell-mediated protection against Staphylococcus aureus infection in mice immunized with the fibrinogen-binding domain of clumping factor A. Infect Immun (2010) 1.13
Attenuation and persistence of and ability to induce protective immunity to a Staphylococcus aureus aroA mutant in mice. Infect Immun (2006) 0.90
CD4 T cell antigens from Staphylococcus aureus Newman strain identified following immunization with heat-killed bacteria. Clin Vaccine Immunol (2012) 0.82
Phytol-based novel adjuvants in vaccine formulation: 2. Assessment of efficacy in the induction of protective immune responses to lethal bacterial infections in mice. J Immune Based Ther Vaccines (2006) 0.81
Generation of a Novel Staphylococcus aureus Ghost Vaccine and Examination of Its Immunogenicity against Virulent Challenge in Rats. Infect Immun (2015) 0.80
The kinetics of emergence and loss of mediator T lymphocytes acquired in response to infection with Mycobacterium tuberculosis. J Immunol (1987) 6.12
Impaired resistance to Mycobacterium tuberculosis infection after selective in vivo depletion of L3T4+ and Lyt-2+ T cells. Infect Immun (1987) 3.87
Natural immunity: a T-cell-independent pathway of macrophage activation, defined in the scid mouse. Immunol Rev (1991) 3.49
Different roles of alpha beta and gamma delta T cells in immunity against an intracellular bacterial pathogen. Nature (1993) 3.47
Survival of Staphylococcus aureus inside neutrophils contributes to infection. J Immunol (2000) 3.08
Intracellular Staphylococcus aureus escapes the endosome and induces apoptosis in epithelial cells. Infect Immun (1998) 2.63
Staphylococcus aureus RN6390 replicates and induces apoptosis in a pulmonary epithelial cell line. Infect Immun (2000) 2.54
Protection against Mycobacterium tuberculosis infection by CD8+ T cells requires the production of gamma interferon. Infect Immun (1998) 2.34
Is Staphylococcus aureus an intracellular pathogen? Trends Microbiol (2000) 2.31
Potential for vaccination against infections caused by Staphylococcus aureus. Vaccine (1991) 2.09
Internalization of Staphylococcus aureus by cultured osteoblasts. Microb Pathog (1995) 2.03
Early appearing gamma/delta-bearing T cells during infection with Calmétte Guérin bacillus. J Immunol (1991) 2.00
Internalization of Staphylococcus aureus by endothelial cells induces cytokine gene expression. Infect Immun (1995) 1.45
Immunobiology of the mammary gland. J Dairy Sci (1997) 1.40
IL-18 promotes type 1 cytokine production from NK cells and T cells in human intracellular infection. J Immunol (1999) 1.24
Cell subpopulations and cytokine expression in cow milk in response to chronic Staphylococcus aureus infection. J Dairy Sci (2001) 1.09
Demonstration of intracellular Staphylococcus aureus in bovine mastitis alveolar cells and macrophages isolated from naturally infected cow milk. FEMS Microbiol Lett (2000) 1.06
Suppression of proliferative response of BoCD4+ T lymphocytes by activated BoCD8+ T lymphocytes in the mammary gland of cows with Staphylococcus aureus mastitis. Vet Immunol Immunopathol (1993) 1.01
Persistence of Staphylococcus aureus on mucosal membranes: superantigens and internalization by host cells. J Lab Clin Med (2000) 0.99
Activity of antibiotics against Staphylococcus aureus within polymorphonuclear neutrophils. Eur J Clin Microbiol Infect Dis (1991) 0.99
Vaccines and diagnostic methods for bovine mastitis: fact and fiction. Adv Vet Med (1999) 0.95
Field trials of a vaccine against bovine mastitis. 1. Evaluation in heifers. J Dairy Sci (1997) 0.94
Modulation of bovine mammary neutrophil function during the periparturient period following in vitro exposure to recombinant bovine interferon gamma. Vet Immunol Immunopathol (1991) 0.91
A field trial with an experimental vaccine against Staphylococcus aureus mastitis in cattle. 2. Antibody response. J Dairy Sci (1994) 0.90
Field trial of a staphylococcal mastitis vaccine in dairy herds: clinical, subclinical and microbiological assessments. Aust Vet J (1996) 0.89
Antibacterial activity of bovine mammary gland lymphocytes following treatment with interleukin-2. J Dairy Sci (1991) 0.86
Phenotype analysis of peripheral blood mononuclear cells in periparturient dairy cows. J Dairy Sci (1999) 0.85
A field trial with an experimental vaccine against Staphylococcus aureus mastitis in cattle. 1. Clinical parameters. J Dairy Sci (1994) 0.85
The effect of interferon-gamma intramammary administration on mammary phagocyte function. Zentralbl Veterinarmed B (1990) 0.84
Diminished mammary gland lymphocyte functions parallel shifts in trafficking patterns during the postpartum period. Proc Soc Exp Biol Med (1996) 0.84
Enhancing bactericidal activity of bovine lymphoid cells during the periparturient period. J Dairy Sci (1996) 0.83
Intramammary immunization with live-attenuated Staphylococcus aureus: microbiological and immunological studies in a mouse mastitis model. FEMS Immunol Med Microbiol (1996) 0.83
Intramammary immunization with live-attenuated Staphylococcus aureus protects mice from experimental mastitis. FEMS Immunol Med Microbiol (1998) 0.83
Mammary infection with Staphylococcus aureus in cows: progress from inoculation to chronic infection and its detection. J Dairy Res (2000) 0.82
Temperature-sensitive mutants ofStaphylococcus aureus: Isolation and preliminary characterization. Curr Microbiol (1993) 0.81
Kinetics of cells and cytokines during immune-mediated inflammation in the mammary gland of cows systemically immunized with Staphylococcus aureus alpha-toxin. Inflamm Res (2000) 0.80
Role played by the programmed death-1-programmed death ligand pathway during innate immunity against Mycobacterium tuberculosis. J Infect Dis (2010) 1.85
Programmed death (PD)-1:PD-ligand 1/PD-ligand 2 pathway inhibits T cell effector functions during human tuberculosis. J Immunol (2008) 1.67
Evolution of multiresistance in nontyphoid salmonella serovars from 1984 to 1998 in Argentina. Antimicrob Agents Chemother (2002) 1.64
IL-17 and IFN-γ expression in lymphocytes from patients with active tuberculosis correlates with the severity of the disease. J Leukoc Biol (2012) 1.34
Mannose-capped lipoarabinomannan- and prostaglandin E2-dependent expansion of regulatory T cells in human Mycobacterium tuberculosis infection. Eur J Immunol (2008) 1.30
Molecular characterization of the capsule locus from non-typeable Staphylococcus aureus. Mol Microbiol (2006) 1.15
Antibodies to capsular polysaccharide and clumping factor A prevent mastitis and the emergence of unencapsulated and small-colony variants of Staphylococcus aureus in mice. Infect Immun (2008) 1.10
STAR gene restriction profile analysis in epidemiological typing of methicillin-resistant Staphylococcus aureus: description of the new method and comparison with other polymerase chain reaction (PCR)-based methods. Diagn Microbiol Infect Dis (2003) 0.98
IFN-gamma production during active tuberculosis is regulated by mechanisms that involve IL-17, SLAM, and CREB. J Infect Dis (2009) 0.97
Capsule-negative Staphylococcus aureus induces chronic experimental mastitis in mice. Infect Immun (2005) 0.95
Differential abilities of capsulated and noncapsulated Staphylococcus aureus isolates from diverse agr groups to invade mammary epithelial cells. Infect Immun (2006) 0.95
Rapid and reliable identification of Staphylococcus aureus capsular serotypes by means of artificial neural network-assisted Fourier transform infrared spectroscopy. J Clin Microbiol (2013) 0.95
Expression of signaling lymphocytic activation molecule-associated protein interrupts IFN-gamma production in human tuberculosis. J Immunol (2004) 0.93
Protein antigens increase the protective efficacy of a capsule-based vaccine against Staphylococcus aureus in a rat model of osteomyelitis. Infect Immun (2013) 0.91
Shedding of tumor necrosis factor receptor 1 induced by protein A decreases tumor necrosis factor alpha availability and inflammation during systemic Staphylococcus aureus infection. Infect Immun (2013) 0.90
Attenuation and persistence of and ability to induce protective immunity to a Staphylococcus aureus aroA mutant in mice. Infect Immun (2006) 0.90
Capsule expression and genotypic differences among Staphylococcus aureus isolates from patients with chronic or acute osteomyelitis. Infect Immun (2009) 0.89
Inducible costimulator: a modulator of IFN-gamma production in human tuberculosis. J Immunol (2006) 0.87
Staphylococcus aureus adaptation to the host and persistence: role of loss of capsular polysaccharide expression. Future Microbiol (2010) 0.87
The length of the Staphylococcus aureus protein A polymorphic region regulates inflammation: impact on acute and chronic infection. J Infect Dis (2012) 0.85
IFNG-mediated immune responses enhance autophagy against Mycobacterium tuberculosis antigens in patients with active tuberculosis. Autophagy (2014) 0.83
Host response to a dam mutant of Salmonella enterica serovar enteritidis with a temperature-sensitive phenotype. Infect Immun (2004) 0.82
Phosphorylation of mitogen-activated protein kinases contributes to interferon γ production in response to Mycobacterium tuberculosis. J Infect Dis (2012) 0.81
Salicylic acid diminishes Staphylococcus aureus capsular polysaccharide type 5 expression. Infect Immun (2009) 0.81
Activation of signaling lymphocytic activation molecule triggers a signaling cascade that enhances Th1 responses in human intracellular infection. J Immunol (2004) 0.80
Staphylococcus aureus Induces Shedding of IL-1RII in Monocytes and Neutrophils. J Innate Immun (2016) 0.78
Characteristics of Community-Associated Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Strains Isolated from Skin and Soft-Tissue Infections in Uruguay. Int J Microbiol (2009) 0.78
Involvement of intestinal inducible nitric oxide synthase (iNOS) in the early stages of murine salmonellosis. FEMS Microbiol Lett (2003) 0.78
CD137 differentially regulates innate and adaptive immunity against Mycobacterium tuberculosis. Immunol Cell Biol (2011) 0.77
Salicylic acid enhances Staphylococcus aureus extracellular adhesin protein expression. Microbes Infect (2011) 0.76
Bayesian approach to model CD137 signaling in human M. tuberculosis in vitro responses. PLoS One (2013) 0.75
Aromatic Compound-Dependent Staphylococcus aureus Is Safe in a Nasal Colonization Leukopenic Murine Model. Int J Microbiol (2012) 0.75
Identification of RANTES as a novel immunomodulator of the maternal allogeneic response. Clin Immunol (2004) 0.75
[The SLAM-associated protein (SAP) regulates IFN-gamma expression in leprosy]. Medicina (B Aires) (2004) 0.75
Nasal carriage of Staphylococcus aureus and Candida species in immunocompetent individuals. Acta Odontol Latinoam (2012) 0.75